| Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome O Devinsky, JH Cross, L Laux, E Marsh, I Miller, R Nabbout, IE Scheffer, ... New England Journal of Medicine 376 (21), 2011-2020, 2017 | 1654 | 2017 |
| Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial O Devinsky, E Marsh, D Friedman, E Thiele, L Laux, J Sullivan, I Miller, ... The Lancet Neurology 15 (3), 270-278, 2016 | 1055 | 2016 |
| Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial EA Thiele, ED Marsh, JA French, M Mazurkiewicz-Beldzinska, ... The Lancet 391 (10125), 1085-1096, 2018 | 834 | 2018 |
| Human and automated detection of high-frequency oscillations in clinical intracranial EEG recordings AB Gardner, GA Worrell, E Marsh, D Dlugos, B Litt Clinical neurophysiology 118 (5), 1134-1143, 2007 | 289 | 2007 |
| GRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine TM Pierson, H Yuan, ED Marsh, K Fuentes‐Fajardo, DR Adams, ... Annals of clinical and translational neurology 1 (3), 190-198, 2014 | 270 | 2014 |
| Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results JP Szaflarski, EM Bebin, AM Comi, AD Patel, C Joshi, D Checketts, ... Epilepsia 59 (8), 1540-1548, 2018 | 216 | 2018 |
| KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients JJ Millichap, KL Park, T Tsuchida, B Ben-Zeev, L Carmant, R Flamini, ... Neurology: Genetics 2 (5), e96, 2016 | 205 | 2016 |
| Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice ITJ Wang, M Allen, D Goffin, X Zhu, AH Fairless, ES Brodkin, SJ Siegel, ... Proceedings of the National Academy of Sciences 109 (52), 21516-21521, 2012 | 202 | 2012 |
| Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females E Marsh, C Fulp, E Gomez, I Nasrallah, J Minarcik, J Sudi, SL Christian, ... Brain 132 (6), 1563-1576, 2009 | 199 | 2009 |
| Pharmacological foundations of cannabis chemovars MA Lewis, EB Russo, KM Smith Planta medica 84 (04), 225-233, 2018 | 194 | 2018 |
| Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results LC Laux, EM Bebin, D Checketts, M Chez, R Flamini, ED Marsh, I Miller, ... Epilepsy research 154, 13-20, 2019 | 176 | 2019 |
| Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases JS Gofshteyn, A Wilfong, O Devinsky, J Bluvstein, J Charuta, MA Ciliberto, ... Journal of child neurology 32 (1), 35-40, 2017 | 174 | 2017 |
| GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers D Li, H Yuan, XR Ortiz-Gonzalez, ED Marsh, L Tian, EM McCormick, ... The American Journal of Human Genetics 99 (4), 802-816, 2016 | 156 | 2016 |
| Data mining neocortical high-frequency oscillations in epilepsy and controls JA Blanco, M Stead, A Krieger, W Stacey, D Maus, E Marsh, J Viventi, ... Brain 134 (10), 2948-2959, 2011 | 149 | 2011 |
| Identification of Arx transcriptional targets in the developing basal forebrain CT Fulp, G Cho, ED Marsh, IM Nasrallah, PA Labosky, JA Golden Human molecular genetics 17 (23), 3740-3760, 2008 | 138 | 2008 |
| Clinical spectrum and genotype–phenotype associations of KCNA2-related encephalopathies S Masnada, UBS Hedrich, E Gardella, J Schubert, C Kaiwar, EW Klee, ... Brain 140 (9), 2337-2354, 2017 | 137 | 2017 |
| Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study E Thiele, E Marsh, M Mazurkiewicz‐Beldzinska, JJ Halford, B Gunning, ... Epilepsia 60 (3), 419-428, 2019 | 135 | 2019 |
| Genetics and genotype–phenotype correlations in early onset epileptic encephalopathy with burst suppression HE Olson, MK Kelly, CM LaCoursiere, R Pinsky, D Tambunan, C Shain, ... Annals of neurology 81 (3), 419-429, 2017 | 134 | 2017 |
| Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4 MV Reid, KA Murray, ED Marsh, JA Golden, RA Simmons, JB Grinspan Journal of neuropathology and experimental neurology 71 (7), 640-653, 2012 | 111 | 2012 |
| MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways AR Paciorkowski, RN Traylor, JA Rosenfeld, JM Hoover, CJ Harris, ... neurogenetics 14, 99-111, 2013 | 110 | 2013 |
T. BenkeVerified email at cuanschutz.edu
